We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04077437
Recruitment Status : Completed
First Posted : September 4, 2019
Last Update Posted : January 6, 2023
Information provided by (Responsible Party):
Multidisciplinary Association for Psychedelic Studies